It is a matter of common sense that when accomplished investors of the caliber of Raamdeo Agrawal take time out to write a Wealth Creation Study and identify a handful of stocks as potential 100-baggers, we ought to take advantage of it.
Raamdeo Agrawal’s Wealth Creation Studies have proven credentials. We have earlier seen how well the five stocks chosen by him in the 2014 study have fared. One of the stocks is a 3+ bagger while the average return is 110% in one year.
The latest 19th Wealth Creation Study is packed with seven winner stocks. On an earlier occasion, I had evaluated the 3-month performance of these stocks. Five stocks had given absolute returns ranging from 21% to 62% while two were flat.
The strong performance continues unabated as is reflected in Shilpa Medicare’s stellar jump of 17% today. The same five stocks have given absolute returns ranging from 17% to 103%. Two are flat.
Here is the updated performance chart of the said seven stocks:
Stock | Price on 10.11.2014 | Price on 10.03.2015 | Return (%) |
Shilpa Medicare | 559 | 925 | 65 |
Aarti Drugs | 783 | 1339 | 71 |
Atul Auto | 383 | 571 | 49 |
Tata Elxsi | 629 | 1281 | 103 |
DCB Bank | 93 | 109 | 17 |
Suven Lifescience | 232 | 246 | 6 |
Granules India | 761 | 821 | 7 |
We must bear in mind that these are small and mid-cap stocks and can be very volatile. Also, they are exposed to several risk factors which can derail the projections made by Raamdeo Agrawal. So, a SIP may be the best way to tuck into these stocks, if one is otherwise convinced about their fundamentals and is prepared to bear the volatility and risk factors.
True we can’t take it for granted.
Excellent article Arjun thanks for sharing this masterpiece.
Regards
bhs
I do not see great fundamentals in any of these except DCB Bank, Tata Elxsi for its promoter pedigree…I can point to several other low fundamental stocks which have done equally well ….I wonder how these companies start performing in this bull market…this stock mentioned here is now more expensive than Lupin, Dr Reddy’s ….whats so special about it ? I am skeptical but I do go by the facts
Stand corrected on Granules India….looks promising …but cannot say whether it will out perform the other pharma stocks
AS OF GRANULES ITS TRUE BUT NOT SURE ABOUT OTHERS